CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 82 enrolled
Drug / intervention
Micra Transcatheter Pacing System (TPS)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03624504
NCT03624504N/ACompleted
CompareCT.gov

China Micra Transcatheter Pacing Study

Medtronic Cardiac Rhythm and Heart Failure·interventional·Posted Aug 10, 2018·Updated Sep 30, 2020

In Brief

A clinical study evaluating Micra Transcatheter Pacing System (TPS) for Bradycardia. Completed, enrolled 82 participants across 7 sites.

Detailed Summary

The China Micra Transcatheter Pacing Study is a prospective, multi-center, single arm human clinical trial utilizing Objective Performance Criterion (OPC) to confirm the safety and efficacy profile of the Micra system for regulatory approval in China.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBradycardia
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 10, 2018
Enrollment StartJul 31, 2018
Primary CompletionAug 29, 2019
Study CompletionJan 20, 2020
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 7.9 years ago

Interventions

Micra Transcatheter Pacing System (TPS)device

Treatment of subjects eligible for the single chamber ventricular pacemaker per study requirements